4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-036529
EVP, Chief Financial Officer sold 974 shares at $25.02 ($24,369)
- EVP, Chief Financial Officer acquired 1,893 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneyer Mark C. EVP, Chief Financial Officer | 2023-06-08 | Option exercise | +1,893 | 23,798 | D | ||
| Schneyer Mark C. EVP, Chief Financial Officer | 2023-06-08 | Sale | −974 | $25.02 | $24,369 | 22,824 | D |
| Derivatives | |||||||
| Schneyer Mark C. EVP, Chief Financial Officer | 2023-06-08 | Option exercise · Restricted Stock Units | −1,893 | 1,893 | D | ||
| Open-market sales · 974 sh · avg $25.02 · $24,369 | |||||||
Loading xslF345X04/doc4.xml…